---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-008116"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2025-02-25T23:59:59+00:00"
generated_at: "2026-05-26T04:30:22.682295+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NanoVibronix stockholders approve reverse stock split (1:2 to 1:11) and warrant issuance at special meeting

## Summary
- Reverse stock split approved: 1,560,759 for, 674,302 against; board may set ratio between 1-for-2 and 1-for-11.
- Issuance of shares underlying warrants from Jan 7 Exchange Agreement approved: 417,111 for, 290,431 against, with 1,528,273 broker non-votes.
- Adjournment proposal approved but not needed as sufficient votes existed for both proposals.
- Record date Jan 17, 2025; 6,138,028 shares outstanding; 2,242,618 votes present at meeting.

## SEC filing metadata
- accession: 0001493152-25-008116
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2025-02-25T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000149315225008116/0001493152-25-008116-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000149315225008116/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-008116
- JSON: https://secwatch.observer/filing/0001493152-25-008116.json
- Plain text: https://secwatch.observer/filing/0001493152-25-008116.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.